|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 60.70 SAR | +3.23% |
|
+5.02% | -4.47% |
| 06:36am | Avalon Pharma Posts Growth in H1 Net Profit, Revenue | MT |
| 07-17 | Derayah Financial Starts Avalon Pharma's Coverage at Buy | MT |
| Market Cap | 2.06B 548M 475M 442M 407M 768M 52.1B 777M 5.2B 2.04B 26.07B 2.01B 86.34B | P/E 2024 |
30.5x | P/E 2025 | 22.9x |
|---|---|---|---|---|---|
| Enterprise Value | 2.09B 556M 481M 449M 413M 779M 52.85B 788M 5.27B 2.07B 26.44B 2.04B 87.58B | EV / Sales 2024 |
6.29x | EV / Sales 2025 | 4.89x |
| Free-Float |
46.88% | Yield 2024 |
1.64% | Yield 2025 | 2.18% |
| 1 day | +2.47% | ||
| 1 week | +4.24% | ||
| Current month | +4.24% | ||
| 1 month | -0.90% | ||
| 3 months | +0.61% | ||
| 6 months | -10.04% | ||
| Current year | -5.18% |
| 1 week | 57.65 |  | 61.65 |
| 1 month | 57.55 | | 64.5 |
| Current year | 53.89 | | 68.51 |
| 1 year | 53.89 | | 79.09 |
| 3 years | 51.54 | | 112.91 |
| 5 years | 51.54 | | 112.91 |
| 10 years | 51.54 | | 112.91 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 45 | 04/09/2018 | |
| Director of Finance/CFO | - | 10/03/2024 | |
| Chief Tech/Sci/R&D Officer | 51 | 31/12/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ahmad Al-Tabbaa
CHM | Chairman | 54 | 09/04/2022 |
Hisham Attar
BRD | Director/Board Member | 45 | 12/09/2023 |
| Director/Board Member | 45 | 09/04/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.30% | +4.24% | -10.87% | - | 548M | |
| +0.57% | -2.50% | +22.30% | +68.07% | 48.95B | |
| +3.09% | +7.65% | +60.81% | +132.38% | 39.36B | |
| +1.25% | +0.72% | -0.65% | +20.70% | 12.39B | |
| -1.17% | -0.64% | +18.79% | +69.11% | 11.76B | |
| +1.53% | -0.38% | +30.75% | +134.53% | 9.14B | |
| +0.08% | +3.24% | +18.48% | +34.07% | 7.05B | |
| +1.61% | -4.86% | +36.73% | -14.17% | 6.86B | |
| +0.49% | +3.64% | +12.07% | +178.19% | 6.7B | |
| +0.79% | +3.84% | -29.57% | +15.81% | 5.67B | |
| Average | +1.07% | -0.03% | +15.88% | +70.97% | 14.84B | |
| Weighted average by Cap. | +1.25% | -0.32% | +28.76% | +82.96% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 394M 105M 90.86M 84.7M 77.9M 147M 9.98B 149M 995M 391M 4.99B 385M 16.53B | 460M 123M 106M 98.99M 91.04M 172M 11.66B 174M 1.16B 457M 5.83B 450M 19.32B |
| Net income | 79.85M 21.26M 18.41M 17.16M 15.79M 29.8M 2.02B 30.14M 202M 79.17M 1.01B 78.09M 3.35B | 97.01M 25.83M 22.37M 20.85M 19.18M 36.21M 2.46B 36.61M 245M 96.18M 1.23B 94.87M 4.07B |
| Net Debt | 42.83M 11.4M 9.88M 9.21M 8.47M 15.99M 1.08B 16.17M 108M 42.47M 543M 41.89M 1.8B | 29.47M 7.85M 6.8M 6.34M 5.83M 11M 746M 11.12M 74.45M 29.22M 373M 28.82M 1.24B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/08/26 | SAR 60.70 | +3.23% | 212,843 |
| 05/08/26 | SAR 58.80 | +0.26% | 24,631 |
| 04/08/26 | SAR 58.65 | +0.60% | 54,892 |
| 03/08/26 | SAR 58.30 | +0.69% | 29,232 |
| 02/08/26 | SAR 57.90 | +0.17% | 40,984 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4016 Stock
Select your edition
All financial news and data tailored to specific country editions
